The role of complement components C1q, MBL and C1 inhibitor in pathogenesis of endometriosis

other OA: gold CC-BY-4.0
📄 Open PDF View on PubMed View at publisher

Abstract

PURPOSE: The purpose of the work was to evaluate possible associations between the complement components C1q, mannose-binding lectin (MBL) and C1 inhibitor (C1INH) with pathogenesis of endometriosis. METHODS: Concentrations of C1q, MBL and C1INH were measured by ELISA in peritoneal fluid (PF) in 80 women with or without endometriosis. RESULTS: Significantly higher PF levels of C1q, MBL and C1INH in women with endometriosis compared to control group were observed (p < 0.0001). A higher concentration of the studied parameter was found in PF of women at the early stage of the disease, as compared to women with advanced endometriosis (p < 0.0001). CONCLUSIONS: Our research suggests that in the peritoneal cavity in women with endometriosis there are abnormal regulations of both the classical and lectin pathways of the complement system. This can suggest impairments in purification of peritoneal cavity from ectopic endometrial cells and augmented local inflammation in endometriosis patients.

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Ascitic Fluid Complement C1 Inhibitor Protein Complement C1q Endometriosis Endometriosis Mannose-Binding Lectin Adult Ascitic Fluid Case-Control Studies Complement C1 Inhibitor Protein Complement C1q Endometriosis Enzyme-Linked Immunosorbent Assay Female Humans Lectins Mannose-Binding Lectin Middle Aged

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
pubmed
last seen: 2026-05-13T22:19:55.107525+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine